Quest Diagnostics

Quest Diagnostics

Health Care Providers & Services
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

$25.4B

Market Cap • 9/11/2026

1990

(36 years)

Founded

1996

(30 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

S&P500 Participant

Index Composite • 2026

Valuation

P/B

3,4

P/S

2,2

P/EBITDA

11,5

P/OCF

13,3

P/FCF

18,8

P/E

24,4

BVPS

67

EPS

9,4

Market Cap

Market Cap

25,4B

EV

31,5B

EV/Revenue

2,7

EV/EBITDA

14,3

EV/EBIT

19,3

Payout

Dividend Per Share

3,3

Dividend Yield

1,4%

Buyback Yield

1,7%

Total Yield

3,1%

Dividend Yield 5Y

1,8%

Payout

34,2%

Retained Earnings

10,4B

Profitability

Gross Margin

33,1%

EBITDA Margin

19,1%

EBIT Margin

14,1%

Net Margin

9,6%

D&A/EBITDA

6,8%

R&D/Revenue

0%

Capex/Revenue

4,8%

Capex/D&A

95,5%

Capex/OCF

29,1%

SBC/OCF

4,6%

% PPE

17,1%

% Goodwill

53,8%

ROE

14,6%

ROIC

8,6%

Growth

CAGR Revenue 5Y

0,9%

CAGR Op. Income 5Y

-9,6%

CAGR Net Income 5Y

-13,8%

CAGR EPS 5Y

-10,9%

CAGR OCF 5Y

-6%

Leverage

N.D./EBITDA

2,6

Debt/Equity

0%

Current Ratio

1,6

Quick Ratio

1,3

Interest Coverage

636,7%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium